Teslexivir(BTA074;AP611074)是一种局部抗病毒剂，为有效的，选择性的两个关键病毒蛋白(E1和E2)相互作用抑制剂，能够抑制人乳头状瘤病毒(HPV)6和11的DNA复制，从而阻止病毒的产生。
货号:ajcx12776
CAS:1075798-37-6
分子式:C35H36BrN3O4
分子量：642.58
溶解度:Soluble in DMSO
纯度：98%
存储：Store at -20°C
库存：现货

Background:

Teslexivir (BTA074; AP 611074) is a topical antiviral agent that is a potent and selective inhibitor of the interaction between two essential viral proteins, E1 and E2, an interaction that is a necessary step for Human Papilloma Virus (HPV) 6 and 11 DNA replication and thus viral production.

[1]. CAS Group Announces Glass Lewis Recommendation That Aviragen Stockholders Vote AGAINST Merger and Emphasizes Value of Teslexivir (BTA074) Program. Jan 31, 2018.